Jonathan H. Kaufman 13D and 13G filings for Lipella Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-03 5:01 pm Unchanged | 2025-02-28 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 8.000% | 0 (Unchanged) | Filing |
| 2025-02-10 5:32 pm Unchanged | 2025-02-06 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 8.000% | 0 (Unchanged) | Filing |
| 2025-01-30 5:27 pm Unchanged | 2025-01-28 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 10.100% | 0 (Unchanged) | Filing |
| 2025-01-23 6:08 pm Unchanged | 2025-01-21 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 11.700% | 0 (Unchanged) | Filing |
| 2025-01-17 8:17 pm Unchanged | 2025-01-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 16.200% | 0 (Unchanged) | Filing |
| 2025-01-03 9:25 pm Unchanged | 2024-12-31 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 16.200% | 0 (Unchanged) | Filing |
| 2024-12-27 9:31 pm Purchase | 2024-12-23 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 16.200% | 212,289 (New Position) | Filing |